Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The primary study hypothesis of this study is to determine whether there is a greater
percentage of patients achieving a triglyceride level of <200 mg/dL with the combination of
simvastatin 20 mg and fenofibrate 160mg than with either simvastatin 20 mg monotherapy or
fenofibrate 160mg monotherapy.